Page last updated: 2024-08-26

bosentan anhydrous and Coronary Vessel Anomalies

bosentan anhydrous has been researched along with Coronary Vessel Anomalies in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Antunes, D; Guimarães, T; Pinto, FJ; Plácido, R; Sousa, I1

Other Studies

1 other study(ies) available for bosentan anhydrous and Coronary Vessel Anomalies

ArticleYear
More than a rare cause of pulmonary hypertension in the elderly.
    Revista portuguesa de cardiologia, 2020, Volume: 39, Issue:3

    Topics: Aged, 80 and over; Bosentan; Computed Tomography Angiography; Coronary Vessel Anomalies; Drug Therapy, Combination; Endothelin Receptor Antagonists; Female; Humans; Hypertension, Pulmonary; Phosphodiesterase 5 Inhibitors; Pulmonary Artery; Scimitar Syndrome; Sildenafil Citrate; Treatment Outcome

2020